247 related articles for article (PubMed ID: 26179124)
1. Efficacy of prednisone for the treatment of ocular myasthenia (EPITOME): A randomized, controlled trial.
Benatar M; Mcdermott MP; Sanders DB; Wolfe GI; Barohn RJ; Nowak RJ; Hehir M; Juel V; Katzberg H; Tawil R;
Muscle Nerve; 2016 Mar; 53(3):363-9. PubMed ID: 26179124
[TBL] [Abstract][Full Text] [Related]
2. Design of the efficacy of prednisone in the treatment of ocular myasthenia (EPITOME) trial.
Benatar M; Sanders DB; Wolfe GI; McDermott MP; Tawil R
Ann N Y Acad Sci; 2012 Dec; 1275():17-22. PubMed ID: 23278573
[TBL] [Abstract][Full Text] [Related]
3. The effect of prednisone on the progression from ocular to generalized myasthenia gravis.
Monsul NT; Patwa HS; Knorr AM; Lesser RL; Goldstein JM
J Neurol Sci; 2004 Feb; 217(2):131-3. PubMed ID: 14706214
[TBL] [Abstract][Full Text] [Related]
4. Ocular motor dysfunction and ptosis in ocular myasthenia gravis: effects of treatment.
Kupersmith MJ; Ying G
Br J Ophthalmol; 2005 Oct; 89(10):1330-4. PubMed ID: 16170126
[TBL] [Abstract][Full Text] [Related]
5. Development of generalized disease at 2 years in patients with ocular myasthenia gravis.
Kupersmith MJ; Latkany R; Homel P
Arch Neurol; 2003 Feb; 60(2):243-8. PubMed ID: 12580710
[TBL] [Abstract][Full Text] [Related]
6. Pediatric Autoimmune Ocular Myasthenia Gravis: Evaluation of Presentation and Treatment Outcomes in a Large Cohort.
Fisher KS; Gill J; Todd HF; Yang MB; Lopez MA; Abid F; Lotze T; Shah VS
Pediatr Neurol; 2021 May; 118():12-19. PubMed ID: 33684630
[TBL] [Abstract][Full Text] [Related]
7. Cigarette Smoking and Activities of Daily Living in Ocular Myasthenia Gravis.
Gratton SM; Herro AM; Feuer WJ; Lam BL
J Neuroophthalmol; 2016 Mar; 36(1):37-40. PubMed ID: 26457691
[TBL] [Abstract][Full Text] [Related]
8. Childhood myasthenia gravis: clinical features and outcomes.
Sri-udomkajorn S; Panichai P; Liumsuwan S
J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S152-7. PubMed ID: 22043769
[TBL] [Abstract][Full Text] [Related]
9. [Analysis for the effect of different regimens on ocular myasthenia gravis in children].
Liu C; Wang X; Xie L; Peng J; Wu L; Zheng X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Nov; 42(11):1275-1279. PubMed ID: 29187654
[TBL] [Abstract][Full Text] [Related]
10. [Ocular myasthenia: clinical course and strategies for treatment].
Marzo ME; Pérez López-Fraile I; Capablo JL; Ara JR; Usón M
Rev Neurol; 1998 Mar; 26(151):398-400. PubMed ID: 9585951
[TBL] [Abstract][Full Text] [Related]
11. The natural history and ophthalmic involvement in childhood myasthenia gravis at the hospital for sick children.
Mullaney P; Vajsar J; Smith R; Buncic JR
Ophthalmology; 2000 Mar; 107(3):504-10. PubMed ID: 10711889
[TBL] [Abstract][Full Text] [Related]
12. The effect of use of pyridostigmine and requirement of vecuronium in patients with myasthenia gravis.
Tripathi M; Kaushik S; Dubey P
J Postgrad Med; 2003; 49(4):311-4; discussion 314-5. PubMed ID: 14699228
[TBL] [Abstract][Full Text] [Related]
13. Ocular myasthenia gravis - How effective is low dose prednisone long term?
Verma R; Wolfe GI; Kupersmith MJ
J Neurol Sci; 2021 Jan; 420():117274. PubMed ID: 33360170
[TBL] [Abstract][Full Text] [Related]
14. A randomized controlled trial of methotrexate for patients with generalized myasthenia gravis.
Pasnoor M; He J; Herbelin L; Burns TM; Nations S; Bril V; Wang AK; Elsheikh BH; Kissel JT; Saperstein D; Shaibani JA; Jackson C; Swenson A; Howard JF; Goyal N; David W; Wicklund M; Pulley M; Becker M; Mozaffar T; Benatar M; Pazcuzzi R; Simpson E; Rosenfeld J; Dimachkie MM; Statland JM; Barohn RJ;
Neurology; 2016 Jul; 87(1):57-64. PubMed ID: 27306628
[TBL] [Abstract][Full Text] [Related]
15. Use of intravenous pulsed cyclophosphamide in severe, generalized myasthenia gravis.
De Feo LG; Schottlender J; Martelli NA; Molfino NA
Muscle Nerve; 2002 Jul; 26(1):31-6. PubMed ID: 12115946
[TBL] [Abstract][Full Text] [Related]
16. Ocular myasthenia gravis: treatment successes and failures in patients with long-term follow-up.
Kupersmith MJ
J Neurol; 2009 Aug; 256(8):1314-20. PubMed ID: 19377863
[TBL] [Abstract][Full Text] [Related]
17. Myasthenia gravis in Jamaican children: a 12-year institutional review.
Melbourne Chambers R; Forrester S; Gray R; Tapper J; Trotman H
Paediatr Int Child Health; 2012 Feb; 32(1):47-50. PubMed ID: 22525448
[TBL] [Abstract][Full Text] [Related]
18. Factors associated with insensitivity to pyridostigmine therapy in Thai patients with ocular myasthenia gravis.
Chirapapaisan N; Tanormrod S; Chuenkongkaew W
Asian Pac J Allergy Immunol; 2007 Mar; 25(1):13-6. PubMed ID: 17891917
[TBL] [Abstract][Full Text] [Related]
19. Celebrating the 70 years of pyridostigmine on therapy of Myasthenia Gravis: historical aspects of the preliminary trials.
Lorenzoni PJ; Kay CSK; Ducci RD; Fustes OJH; Werneck LC; Scola RH
Arq Neuropsiquiatr; 2020 Mar; 78(3):179-181. PubMed ID: 32215460
[TBL] [Abstract][Full Text] [Related]
20. Myasthenia gravis: an unusual cause of diplopia in polymyalgia rheumatica.
Fernández-Castro M; Andreu JL; Muñoz P; Ornilla E
Clin Exp Rheumatol; 2004; 22(4):505. PubMed ID: 15301257
[No Abstract] [Full Text] [Related]
[Next] [New Search]
